US equities |
MU $934.27 ▲+0.00% INTC $92.07 ▲+0.00% SNDK $1,330.05 ▲+0.00% AMZN $243.79 ▲+0.00% NVDA $213.66 ▲+0.00% AAPL $348.91 ▲+0.00% GOOGL $283.82 ▲+0.00% MSFT $530.14 ▲+0.00%
FinancialContent

Hls Therapeutics Inc (TSX:HLS)

4.560 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Hls Therapeutics Inc

News headline image
Esperion Partner HLS Therapeutics Announces Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease
From Esperion Therapeutics, Inc.
Via GlobeNewswire
News headline image
Sidoti Winter Virtual Small Cap Investor Conference
- Presentation Times and Weblinks Released for Over 70 Presenting Companies - Wednesday and Thursday, January 19th-20th, 2022 NEW YORK, NY / ACCESSWIRE / January 18, 2022 / Sidoti & Company, LLC has... 
From Sidoti & Company, LLC
Via AccessWire